HTL-0033744

N/A

Report date: 2024/03/28 11:55:26
NME

Base Information

Drug NameHTL-0033744
Drug Alias NameHTL-0033744HTL0033744HTL’744
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProstanoid EP4 receptor agonists
TargetsProstanoid EP4 receptor
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNxera Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNxera Pharma Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A